2014-15年儿童接种灭活与减毒活流感疫苗后的抗体依赖性细胞介导的细胞毒性抗体反应
研究招募5-17岁儿童,2014年秋季接种三价灭活疫苗(IIV3)或四价减毒活疫苗(LAIV4),检测针对2014-15 H3N2疫苗株(A/Texas/50/2012)及漂移株(A/Switzerland/9715293/2013)的ADCC抗体反应。85名儿童接种LAIV4,45名接种IIV3。2014-15接种IIV3且前一季接种LAIV4者,针对疫苗株的ADCC抗体几何平均倍数升高(MFR)为1.6(95%CI 1.23-2.11),该组对漂移株也有可检测的ADCC反应。其他疫苗诱导的ADCC反应微小,且不受疫苗类型或接种顺序影响。
要点
- 2014-15接种IIV3且前一季接种LAIV4的儿童,针对疫苗株TX12的ADCC抗体MFR=1.6(95%CI 1.23-2.11)。
- 该组对漂移株SW13也有可检测的ADCC反应。
- 前一季未接种的LAIV4受种者对SW13有适度ADCC反应,MFR=1.18(95%CI 1.10-1.25)。
核心结论
- 儿童先接种LAIV4再接种IIV3可产生适度的ADCC抗体增加,包括对新兴漂移株的部分交叉反应;其他疫苗诱导的ADCC反应微小,且不受疫苗类型或接种顺序影响。
研究设计与样本
- 2014年秋季招募5-17岁儿童,5-9岁按当时推荐接种LAIV4,年长儿童随机分配至IIV3或LAIV4;采集接种前后血清,用微孔板流式细胞术和NK细胞系检测针对TX12和SW13的ADCC抗体反应,并按2013-14和2014-15两季疫苗接种顺序分层。
主要发现
- 85名儿童接种LAIV4,45名接种IIV3。
- 接种前ADCC活性在上一季接种过任何疫苗的儿童中最高。
- 2014-15接种IIV3且前一季接种LAIV4者,针对TX12的ADCC抗体MFR=1.6(95%CI 1.23-2.11),该组对SW13也有可检测的ADCC反应。
- 前一季未接种的LAIV4受种者对SW13有适度ADCC反应,MFR=1.18(95%CI 1.10-1.25)。
- 2013-14接种IIV3的儿童,2014-15接种后ADCC反应无显著变化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Seasonal influenza vaccines aim to induce strain-specific neutralizing antibodies. Non-neutralizing antibodies may be more broadly cross-reactive and still protect through mechanisms including antibody-dependent cell-mediated cytotoxicity (ADCC). Influenza vaccines may stimulate ADCC antibodies in adults, but whether they do so in children is unknown. Here we examined how vaccination affects cross-reactive ADCC antibody responses in children after receipt of inactivated trivalent vaccine (IIV3) or quadrivalent live-attenuated vaccine (LAIV4). METHODS: Children aged 5-17 were recruited in fall 2014 to provide pre- and post-vaccination serum samples. Children aged 5-9 received LAIV4 based on then-current recommendation, and older children were randomly assigned to IIV3 or LAIV4. We used microtiter-plate-based flow cytometry with an NK cell line to examine ADCC antibody responses to the 2014-15 H3N2 vaccine component (A/Texas/50/2012 [TX12]) and a drifted strain, A/Switzerland/9715293/2013 (SW13). Responses were stratified by two-season (2013-14 and 2014-15) vaccine sequence. RESULTS: Eighty-five children received LAIV4 and 45 received IIV3. Prevaccination ADCC activity was highest in children who had received any vaccine in the prior season. Increase in ADCC antibody responses against the vaccine strain TX12 following vaccination was greatest for participants who received IIV3 in 2014-15 and LAIV4 in the prior season (geometric mean fold rise [MFR] = 1.6, 95% CI. 1.23-2.11). This group also had a detectable ADCC response to the drifted SW13 strain. There was a modest ADCC response against SW13 in LAIV4 recipients who were unvaccinated in the previous season (MFR = 1.18, 95% CI 1.10-1.25). There were no significant changes in 2014-15 ADCC response to vaccination among children who had received IIV3 in 2013-14. CONCLUSIONS: Vaccinating children with IIV3 after prior receipt of LAIV4 generated a modest increase in ADCC antibodies, including some cross-reactivity with an emerging drift variant. Other vaccine-induced ADCC responses were minimal and not affected by vaccine type or sequence.
引用
- Florek K, Mutschler J, McLean HQ, et al. Antibody-dependent cell-mediated cytotoxicity antibody responses to inactivated and live-attenuated influenza vaccination in children during 2014-15. Vaccine. 2019. PMID: 31753674. doi:10.1016/j.vaccine.2019.10.060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。